Glenn Rice, Ph.D.
Glenn Rice, Ph.D. is a Silicon Valley entrepreneur that has been involved with the founding and building of eight venture capital backed biotech and internet tech companies as founder/CEO/COO/VP Research. The companies have led to multiple FDA approved drugs in cancer, autoimmune diseases, cardiovascular, ocular and dermatology; new medical service platforms; and significant investor returns through product royalties, licensing, IPO’s or acquisitions.
He is former COO of Pharmacyclics (NASDAQ:PCYC), and after restructuring and re-focusing, was purchased by Abbvie, Inc. for $21 billion within 4 years (starting valuation was $40 million). He is the former VP of Research and Board Director of NASDAQ listed ILEX Oncology, which was sold to Genzyme Corp. in 2004 for $1 billion. Prior to ILEX he was a founder and CEO of Convergence Pharmaceuticals, Inc., a Boston-based oncology company; a founder and Director of EmergingMed, an online clinical trial prequalification company; and a past Director and co-founder of C-PATH Institute, a non-profit Institute that is focused on drug development and regulatory innovation. He has also headed ~170 scientists at the Biosciences Division at SRI International (Stanford Research Institute) in Menlo Park and has significant international business experience, having established and built three biotech companies in China, as well as having extensive track records in India, Taiwan and Singapore.
Dr. Rice began his career as a laboratory director at Genentech, and is an inventor on 22 patents or patent applications, authored over 75 manuscripts and book chapters, and has had extensive experience raising substantial private and public equity and corporate partnerships. Currently he is developing a new anticancer drug for children with neuroblastoma as President of MetronomX, LLC, and serving on several boards of private high tech companies as well as the board of the Silicon Valley Venture Capital Roundtable. He was appointed by the governor of California to the State Board of Trustees of the Medical Health Professionals Foundation. He is a Paul Harris Fellow of the Rotary Club and involved with a variety of other public policy groups in CA.